Filing search / Context Therapeutics Inc. / "Independent"

Search information

Context Therapeutics Inc.

Companies

"Independent"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

133 results

Newest first Best match first

S-3

EX-4.3

CNTX Context Therapeutics Inc.

Shelf registration

by it as provided in Sections 8.3 or 8.4 which, in the opinion of a nationally recognized firm of independent certified public accountants or investment bank … recognized firm of independent public accountants or investment bank expressed in a written certification thereof delivered to the Trustee, to pay

6 Nov 24

4:42pm

S-3

EX-5.1

CNTX Context Therapeutics Inc.

Shelf registration

of and information provided by officers and employees of the Company as to the accuracy of such factual matters, in each case without independent verification

6 Nov 24

4:42pm

S-3

EX-23.2

CNTX Context Therapeutics Inc.

Shelf registration

Exhibit 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement

6 Nov 24

4:42pm

S-3

CNTX Context Therapeutics Inc.

Shelf registration

writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are based on independent industry … by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions

6 Nov 24

4:42pm

10-Q

2024 Q3

CNTX Context Therapeutics Inc.

Quarterly report

and other data generated by independent third parties, by third parties on our behalf and by us concerning markets for CTIM-76, our Claudin 6 (“CLDN6

6 Nov 24

4:02pm

Context to obtain exclusive development and commercialization rights to BA3362

Context to obtain exclusive development and commercialization rights to BA3362

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors

7 Aug 24

4:07pm

10-Q

mhj0mf752owuck1h 39

Quarterly report

7 Aug 24

4:07pm

Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

Submission of Matters to a Vote of Security Holders

Prospectus supplement

24 May 24

7:31am

24 May 24

7:31am

24 May 24

7:31am

10-Q

f3z2uaftf8s7mtf

Quarterly report

8 May 24

4:03pm

Context Therapeutics Announces $100 Million Private Placement

Context Therapeutics Announces $100 Million Private Placement

Context Therapeutics Announces $100 Million Private Placement

7:37am

Filing search / Context Therapeutics Inc. / "Independent"

133 results

Top filers

Top filing types

Recent filing years